At 7x earnings with a 33.50% ROE, CDLR screens statistically cheap, but this is not a clean value story. The absence of a Forward P/E and PEG removes visibility into earnings durability, while the Altman Z-Score of 1.4 places the company in financial distress territory despite a respectable Piotroski F-Score of 7. The market is clearly discounting something material: either earnings normalization risk (EPS dropping to an estimated $3.55 next year) or balance sheet fragility. This is a classic deep-value setup where current profitability looks strong, but forward uncertainty and solvency risk prevent re-rating.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.